Skip to main content

Table 6 Evaluation of response to 188Re-HEDP treatment (n = 18), compared to the status before dose administration.

From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose

 

Pain relief

Analgesic intake

Opiate intake

Decrease

78%

62%

100%*

Increase

11%

17%

0%

No change

11%

5%

0%

  1. * 33% abandoned opiate intake